The Role of the Microenvironment in Prostate Cancer-Associated Bone Disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of the Microenvironment in Prostate Cancer-Associated Bone Disease
Authors
Keywords
Bone microenvironment, Prostate cancer, Bone metastasis, Therapeutic strategies
Journal
Current Osteoporosis Reports
Volume 14, Issue 5, Pages 170-177
Publisher
Springer Nature
Online
2016-08-26
DOI
10.1007/s11914-016-0323-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dual-Action Combination Therapy Enhances Angiogenesis while Reducing Tumor Growth and Spread
- (2015) Ping-Pui Wong et al. CANCER CELL
- Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer
- (2015) Aimalie L. Hardaway et al. CLINICAL & EXPERIMENTAL METASTASIS
- Mitotic quiescence, but not unique “stemness,” marks the phenotype of bone metastasis-initiating cells in prostate cancer
- (2015) Ning Wang et al. FASEB JOURNAL
- Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
- (2015) Xiaofeng Zheng et al. NATURE
- Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
- (2015) Kari R. Fischer et al. NATURE
- The evolutionary history of lethal metastatic prostate cancer
- (2015) Gunes Gundem et al. NATURE
- Radium-223 Dichloride for Metastatic Castration-resistant Prostate Cancer: The Urologist's Perspective
- (2015) Neal D. Shore UROLOGY
- Targeting Bone Metabolism in Patients with Advanced Prostate Cancer: Current Options and Controversies
- (2015) Tilman Todenhöfer et al. International Journal of Endocrinology
- Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms
- (2015) Mackenzie Herroon et al. Oncotarget
- Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases
- (2014) Aimalie L. Hardaway et al. CANCER AND METASTASIS REVIEWS
- Contributions of the Host Microenvironment to Cancer-Induced Bone Disease
- (2014) Sam W.Z. Olechnowicz et al. CANCER RESEARCH
- Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone
- (2014) P. D. Ottewell et al. ENDOCRINE-RELATED CANCER
- Prostate Cancer Cells Preferentially Home to Osteoblast-rich Areas in the Early Stages of Bone Metastasis: Evidence From In Vivo Models
- (2014) Ning Wang et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Dissecting the Role of Bone Marrow Stromal Cells on Bone Metastases
- (2014) Denise Buenrostro et al. Biomed Research International
- Targeting the Tumor Microenvironment: From Understanding Pathways to Effective Clinical Trials
- (2013) H. Fang et al. CANCER RESEARCH
- Understanding and Targeting Osteoclastic Activity in Prostate Cancer Bone Metastases
- (2013) J.L. Sottnik et al. CURRENT MOLECULAR MEDICINE
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling
- (2013) J Luo et al. ONCOGENE
- Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis
- (2013) Younghun Jung et al. Nature Communications
- Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments
- (2013) Arjun Muralidharan et al. INFLAMMOPHARMACOLOGY
- The prostate cancer bone marrow niche: more than just ‘fertile soil’
- (2012) Elisabeth A Pedersen et al. ASIAN JOURNAL OF ANDROLOGY
- Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials
- (2012) Allan Lipton et al. EUROPEAN JOURNAL OF CANCER
- Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401
- (2012) William Kevin Kelly et al. JOURNAL OF CLINICAL ONCOLOGY
- Loss of TGF- Responsiveness in Prostate Stromal Cells Alters Chemokine Levels and Facilitates the Development of Mixed Osteoblastic/Osteolytic Bone Lesions
- (2012) X. Li et al. MOLECULAR CANCER RESEARCH
- Bisphosphonates in oncology
- (2011) Robert E. Coleman et al. BONE
- Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
- (2011) Peter Friedl et al. CELL
- Steps in prostate cancer progression that lead to bone metastasis
- (2011) Jung-Kang Jin et al. INTERNATIONAL JOURNAL OF CANCER
- Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow
- (2011) Yusuke Shiozawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
- (2011) Matthew R Smith et al. LANCET
- Combination of Bevacizumab and Docetaxel in Docetaxel-Pretreated Hormone-Refractory Prostate Cancer: A Phase 2 Study
- (2008) Giuseppe Di Lorenzo et al. EUROPEAN UROLOGY
- Annexin II/Annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer
- (2008) Yusuke Shiozawa et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation